Abstract：Objective To explore the correlation between cerebral glucose metabolism and cognitive function in Alzheimer’s disease patients based on positron emission tomography / computed tomography (PET/CT). Methods Clinical data of 31 patients with primary AD in Gansu Provincial People’s Hospital (hereinafter referred to as “our hospital”) from September 2016 to October 2019 were analyzed. According to the mini-mental state examination (MMSE), the patients were divided into mild to moderate AD group (22 cases, 12≤MMSE< 24 points) and severe AD group (9 cases, MMSE< 12 points). The control group was 57 healthy people who underwent physical examination in our hospital during the same period. In PET/CT examination, the imaging agent was fluorodeoxy glucose (18F-FDG), the image fusion and reconstruction were processed by PHILIPS Syntegra software, and SUVavg (Br/Bl) value was obtained after the correction of interest area. At the same time, the correlation between brain glucose metabolism and cognitive function in AD patients was analyzed. Results There was a positive correlation between SUVavg (Br/Bl) value in bilateral temporal lobe and recall power score in MMSE score in AD patients (r = 0.516, P ＜ 0.05). SUVavg (Br/Bl) value of right parietal lobe in mild to moderate AD group was lower than that in control group (P < 0.05). Conclusion The progressive decrease of 18F-FDG glucose metabolism in temporal lobe of AD patients is consistent with the decline of the ability to memorize score in MMSE, and PET/CT can earlier reflect the functional damage of right parietal lobe in mild to moderate AD patients.
王艳艳1 李晓霞2 夏欢3 罗琴4. 基于PET/CT探索阿尔茨海默病患者脑葡萄糖代谢与认知功能的相关性[J]. 中国医药导报, 2021, 18(28): 152-155.
WANG Yanyan1 LI Xiaoxia2 XIA Huan3 LUO Qin4. Correlation between cerebral glucose metabolism and cognitive function in Alzheimer’s disease patients based on PET/CT. 中国医药导报, 2021, 18(28): 152-155.
[1] 温世荣，于艳红，王德生，等.凋亡相关蛋白在阿尔茨海默病病理改变中的作用[J].中国医药导报，2019，16（25）：16-19.
[2] Ihara R，Vincent BD，Baxter MR，et al. Relative neuron loss in hippocampal sclerosis of aging and Alzheimer’s disease [J]. Ann Neurol，2018，84（5）：741-753.
[3] Doan NT，Engvig A，Zaske K，et al. Distinguishing early and late brain aging from the Alzheimer’s disease spectrum：Consistent morphological patterns across independent samples [J]. Neuroimage，2017，158：282-295.
[4] Pini L，Pievani M，Bocchetta M，et al. Brain atrophy in Alzheimer’s disease and aging [J]. Ageing Res Rev，2016， 30：25-48.
[5] 刘建荣，张珊珊，杨振芸，等.阿尔兹海默病患者家属的主观幸福感与社会支持的关系[J].中国医药导报，2018， 15（14）：165-168.
[6] Dubois B，Feldman HH，Jacova C，et al. Research criteria for the diagnosis of Alzheimer’s disease：revising the NINCDS-ADRDA criteria [J]. Lancet Neurol，2007，6（8）：734-746.
[7] Devenney E，Hodges JR. The Mini-mental state examination：pitfalls and limitations [J]. Pract Neurol，2017，17（1）：79-80.
[8] 刘国兵，李艳丽，呼岩，等.血液本底对肝脏18F-FDG SUV的影响及校正方法探讨[J].中华核医学与分子影像杂志，2016，36（2）：166-170.
[9] Dubois B，Feldman H，Jacova C，et al. Advancing research diagnostic criteria for Alzheimer’s disease：the IWG-2 criteria [J]. Lancet Neurol，2014，13（6）：614-629.
[10] 潘野雄，蒋皆恢，王敏，等.基于神经影像的复杂脑网络技术用于阿尔兹海默症的研究进展[J].国际放射医学核医学杂志，2020，44（1）：16-21.
[11] Rice L，Bisdas S. The diagnostic value of FDG and amyloid PET in Alzheimer’s disease-A systematic review [J]. Eur J Radiol，2017，94：16-24.
[12] Lestercoll N，Rivera EJ，Soscia SJ，et al. Intracerebral streptozotocin model of type 3 diabetes：Relevance to sporadic Alzheimer’s disease [J]. J Alzheimers Dis，2006， 9（1）：13-33.
[13] Palop JJ，Mucke L. Amyloid-[beta]-induced neuronal dysfunction in Alzheimer’s disease：from synapses toward neural networks [J]. Nat Neurosci，2010，13（7）：812-818.
[14] Ossenkoppele R，Schonhaut DR，Sch?觟ll M，et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease [J]. Brain，2016，139（5）：1551-1567.
[15] Pascoal TA，Mathotaarachchi S，Mohades S，et al. Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer’s disease [J]. Mol Psychiatr，2017，22（2）：306-311.
[16] Der Thiel MV，Rodriguez C，De Ville DV，et al. Regional Cerebral Perfusion and Cerebrovascular Reactivity in Elderly Controls With Subtle Cognitive Deficits [J]. Front Aging Neurosci，2019，11：19.
[17] Guan S，Jiang R，Bian H，et al. The profiles of nonstationarity and nonlinearity in the time series of resting-state brain networks [J]. Front Aging Neurosci，2020，24（4）：225-253.
[18] Zhou M，Zhang F，Zhao L，et al. Entorhinal cortex：a good biomarker of mild cognitive impairment and mild Alzheimer’s disease [J]. Rev Neuroscience，2016，27（2）：185-195.
[19] Pinto TCC，Machado L，Bulgacov TM，et al. Is the Montreal Cognitive Assessment （MoCA） screening superior to the Mini-Mental State Examination （MMSE） in the detection of mild cognitive impairment（MCI）and Alzheimer’s Disease（AD）in the elderly? [J]. Int Psychogeriatr，2019， 31（4）：491-504.
[20] Berlingeri M，Bottini G，Basilico S，et al. Anatomy of the episodic buffer：A voxel-based morphometry study in patients with dementia [J]. Behav Neurol，2008，19（1/2）：29-34.
[21] Deture MA，Dickson DW. The neuropathological diagnosis of Alzheimer’s disease [J]. Mol Neurodegener，2019， 14（1）：1-18.
[22] Pettigrew C，Soldan A，Sloane K，et al. Progressive medial temporal lobe atrophy during preclinical Alzheimer’s disease [J]. Neuroimage Clin，2017，16：439-446.
[23] 徐盼盼，杨宁，李淑龙.基于支持张量机算法和3D脑白质图像的阿尔兹海默症诊断[J].中山大学学报：自然科学版，2018，57（2）：52-60.
[24] 郭少楠，陈明钟，官方萍，等.尿AD7c-NTP在不同认知功能水平人群中的比较研究[J].中外医学研究，2020， 18（24）：6-8.
[25] 黄鹤鸣，陈实，赵艳杰，等.神经细胞凋亡与阿尔茨海默病大鼠模型炎症因子相关性研究[J].中国医学工程，2015，23（6）：28-29.
[26] Samper-González J，Burgos N，Bottani S，et al. Reproducible evaluation of classification methods in Alzheimer’s disease：Framework and application to MRI and PET data [J]. Neuroimage，2018，183：504-521.
京公网安备 11010502046598号